Beijing, 100050
China
Checkpoint inhibitors; Glioma; CTLA-4; immune response; RNA-seq
cancer immunity; pituitary adenomas; tumor-infiltrating immune cells; immunotherapy
Glioblastoma, Tumor Microenvironment, CTLA4, Macrophage, Multi‐omics